Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 12.80
-0.35 (-2.66%)
Mar 4, 2026, 10:39 AM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.66 billion as of March 3, 2026. Its market cap has decreased by -27.07% in one year.
Market Cap
7.66B
Enterprise Value
2.82B
Revenue
301.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.80
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.66B, a decrease of -66.60%. That is a compound annual growth rate of -34.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 7.83B | -12.37% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gongwin Biopharm Holdings | 9.91B |
| PharmaEngine | 9.02B |
| TaiGen Biopharmaceuticals Holdings | 8.72B |
| Adimmune | 7.50B |
| Mycenax Biotech | 6.73B |
| Savior Lifetec | 5.93B |
| Sinphar Pharmaceutical | 5.78B |
| AnnJi Pharmaceutical | 5.60B |